Welcome to our Corporate client solution
Your IP is registered with the company mentioned above and provides access to Life Science Sweden.
Eurocine Vaccines andra kliniska fas I/II-studie med influensavaccinkandidaten Immunose flu visade på god säkerhet och tolerabilitet hos vuxna patienter.